Biblio

Export 1374 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is H  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
1
N. Smailagic, Lafortune, L., Kelly, S., Hyde, C., and Brayne, C., “18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1175-1194, 2018.
2
A. A. Sepehry, Lee, P. E., Hsiung, G. - Y. R., B Beattie, L., Feldman, H. H., and Jacova, C., “The 2002 NIMH Provisional Diagnostic Criteria for Depression of Alzheimer's Disease (PDC-dAD): Gauging their Validity over a Decade Later.”, J Alzheimers Dis, vol. 58, no. 2, pp. 449-462, 2017.
M. Heath, Shellington, E., Titheridge, S., Gill, D. P., and Petrella, R. J., “A 24-Week Multi-Modality Exercise Program Improves Executive Control in Older Adults with a Self-Reported Cognitive Complaint: Evidence from the Antisaccade Task.”, J Alzheimers Dis, vol. 56, no. 1, pp. 167-183, 2017.
3
X. - Y. He, Dobkin, C., W Brown, T., and Yang, S. - Y., “3-Hydroxyacyl-CoA and Alcohol Dehydrogenase Activities of Mitochondrial Type 10 17β-Hydroxysteroid Dehydrogenase in Neurodegeneration Study.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1487-1497, 2022.
5
L. Chen, Shen, Q., Xu, S., Yu, H., Pei, S., Zhang, Y., He, X., Wang, Q. Z., and Li, D., “5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 85, no. 2, pp. 573-585, 2022.
A
Q. - F. Zhao, Wan, Y., Wang, H. - F., Sun, F. - R., Hao, X. - K., Tan, M. - S., Tan, C. - C., Zhang, D. - Q., Tan, L., and Yu, J. - T., “ABCA7 Genotypes Confer Alzheimer's Disease Risk by Modulating Amyloid-β Pathology.”, J Alzheimers Dis, vol. 52, no. 2, pp. 693-703, 2016.
Y. H. Fu, Hsiao, J. - H. T., Paxinos, G., Halliday, G. M., and Kim, W. Scott, “ABCA7 Mediates Phagocytic Clearance of Amyloid-β in the Brain.”, J Alzheimers Dis, vol. 54, no. 2, pp. 569-84, 2016.
Y. H. Fu, Hsiao, J. - H. T., Paxinos, G., Halliday, G. M., and Kim, W. Scott, “ABCA7 Mediates Phagocytic Clearance of Amyloid-β in the Brain.”, J Alzheimers Dis, vol. 54, no. 2, pp. 569-84, 2016.
L. Ni, Liu, R., Yin, Z., Zhao, H., Nedelska, Z., Hort, J., Zhou, F., Wu, W., Zhang, X., Li, M., Yu, H., Zhu, B., Xu, Y., and Zhang, B., “Aberrant Spontaneous Brain Activity in Patients with Mild Cognitive Impairment and concomitant Lacunar Infarction: A Resting-State Functional MRI Study.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1243-54, 2016.
C. Babiloni, Del Percio, C., Lizio, R., Noce, G., Cordone, S., Lopez, S., Soricelli, A., Ferri, R., Pascarelli, M. Teresa, Nobili, F., Arnaldi, D., Famá, F., Aarsland, D., Orzi, F., Buttinelli, C., Giubilei, F., Onofrj, M., Stocchi, F., Stirpe, P., Fuhr, P., Gschwandtner, U., Ransmayr, G., Caravias, G., Garn, H., Sorpresi, F., Pievani, M., D'Antonio, F., de Lena, C., Güntekin, B., Hanoğlu, L., Başar, E., Yener, G., Emek-Savaş, D. Durusu, Triggiani, A. Ivano, Franciotti, R., Frisoni, G. B., Bonanni, L., and De Pandis, M. Francesca, “Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study.”, J Alzheimers Dis, vol. 59, no. 1, pp. 339-358, 2017.
C. Babiloni, Del Percio, C., Lizio, R., Noce, G., Lopez, S., Soricelli, A., Ferri, R., Pascarelli, M. Teresa, Catania, V., Nobili, F., Arnaldi, D., Famá, F., Aarsland, D., Orzi, F., Buttinelli, C., Giubilei, F., Onofrj, M., Stocchi, F., Vacca, L., Stirpe, P., Fuhr, P., Gschwandtner, U., Ransmayr, G., Garn, H., Fraioli, L., Pievani, M., Frisoni, G. B., D'Antonio, F., de Lena, C., Güntekin, B., Hanoğlu, L., Başar, E., Yener, G., Emek-Savaş, D. Durusu, Triggiani, A. Ivano, Franciotti, R., Taylor, J. Paul, De Pandis, M. Francesca, and Bonanni, L., “Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases.”, J Alzheimers Dis, vol. 62, no. 1, pp. 247-268, 2018.
N. L. Spartano, Himali, J. J., Trinquart, L., Yang, Q., Weinstein, G., Satizabal, C. L., Dukes, K. A., Beiser, A. S., Murabito, J. M., Vasan, R. S., and Seshadri, S., “Accelerometer-Measured, Habitual Physical Activity and Circulating Brain-Derived Neurotrophic Factor: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 85, no. 2, pp. 805-814, 2021.
R. Skogseth, Hortobágyi, T., Soennesyn, H., Chwiszczuk, L., Ffytche, D., Rongve, A., Ballard, C., and Aarsland, D., “Accuracy of Clinical Diagnosis of Dementia with Lewy Bodies versus Neuropathology.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1139-1152, 2017.
M. K. Lupton, Medland, S. E., Gordon, S. D., Goncalves, T., MacGregor, S., Mackey, D. A., Young, T. L., Duffy, D. L., Visscher, P. M., Wray, N. R., Nyholt, D. R., Bain, L., Ferreira, M. A., Henders, A. K., Wallace, L., Montgomery, G. W., Wright, M. J., and Martin, N. G., “Accuracy of Inferred APOE Genotypes for a Range of Genotyping Arrays and Imputation Reference Panels.”, J Alzheimers Dis, vol. 64, no. 1, pp. 49-54, 2018.
K. Dhananjayan, Gunawardena, D., Hearn, N., Sonntag, T., Moran, C., Gyengesi, E., Srikanth, V., and Münch, G., “Activation of Macrophages and Microglia by Interferon-γ and Lipopolysaccharide Increases Methylglyoxal Production: A New Mechanism in the Development of Vascular Complications and Cognitive Decline in Type 2 Diabetes Mellitus?”, J Alzheimers Dis, vol. 59, no. 2, pp. 467-479, 2017.
A. Tramutola, Pupo, G., Di Domenico, F., Barone, E., Arena, A., Lanzillotta, C., Broekaart, D., Blarzino, C., Head, E., D Butterfield, A., and Perluigi, M., “Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype.”, J Alzheimers Dis, vol. 52, no. 1, pp. 359-71, 2016.
T. C. Durazzo, Korecka, M., Trojanowski, J. Q., Weiner, M. W., Hara, R. O. ', Ashford, J. W., and Shaw, L. M., “Active Cigarette Smoking in Cognitively-Normal Elders and Probable Alzheimer's Disease is Associated with Elevated Cerebrospinal Fluid Oxidative Stress Biomarkers.”, J Alzheimers Dis, vol. 54, no. 1, pp. 99-107, 2016.
R. L. H. Handels, Joore, M. A., Vos, S. J. B., Aalten, P., Ramakers, I. H. G. B., Rikkert, M. Olde, Scheltens, P., Jansen, W. J., Visser, P. - J., van Berckel, B. M. N., van Domburg, P., Smid, M., Hoff, E., Hoogmoed, J., Bouwman, F., Claassen, J., Leentjens, A. F. G., Wolfs, C. A. G., Severens, J. L., and Verhey, F. R. J., “Added Prognostic Value of Cerebrospinal Fluid Biomarkers in Predicting Decline in Memory Clinic Patients in a Prospective Cohort.”, J Alzheimers Dis, vol. 52, no. 3, pp. 875-85, 2016.
R. L. H. Handels, Joore, M. A., Vos, S. J. B., Aalten, P., Ramakers, I. H. G. B., Rikkert, M. Olde, Scheltens, P., Jansen, W. J., Visser, P. - J., van Berckel, B. M. N., van Domburg, P., Smid, M., Hoff, E., Hoogmoed, J., Bouwman, F., Claassen, J., Leentjens, A. F. G., Wolfs, C. A. G., Severens, J. L., and Verhey, F. R. J., “Added Prognostic Value of Cerebrospinal Fluid Biomarkers in Predicting Decline in Memory Clinic Patients in a Prospective Cohort.”, J Alzheimers Dis, vol. 52, no. 3, pp. 875-85, 2016.
R. L. H. Handels, Joore, M. A., Vos, S. J. B., Aalten, P., Ramakers, I. H. G. B., Rikkert, M. Olde, Scheltens, P., Jansen, W. J., Visser, P. - J., van Berckel, B. M. N., van Domburg, P., Smid, M., Hoff, E., Hoogmoed, J., Bouwman, F., Claassen, J., Leentjens, A. F. G., Wolfs, C. A. G., Severens, J. L., and Verhey, F. R. J., “Added Prognostic Value of Cerebrospinal Fluid Biomarkers in Predicting Decline in Memory Clinic Patients in a Prospective Cohort.”, J Alzheimers Dis, vol. 52, no. 3, pp. 875-85, 2016.
O. Turró-Garriga, Calvó-Perxas, L., Vilalta-Franch, J., Hernández-Ferrándiz, M., Flaqué, M., Linares, M., Cullell, M., Gich, J., Casas, I., Perkal, H., and Garre-Olmo, J., “Adherence to Clinical Practice Guidelines during Dementia Work-Up in a Real-World Setting: A Study from the Registry of Dementias of Girona.”, J Alzheimers Dis, vol. 59, no. 3, pp. 997-1007, 2017.
M. Waragai, Ho, G., Takamatsu, Y., Wada, R., Sugama, S., Takenouchi, T., Masliah, E., and Hashimoto, M., “Adiponectin Paradox as a Therapeutic Target in Alzheimer's Disease.”, J Alzheimers Dis, vol. 76, no. 4, pp. 1249-1253, 2020.
M. Waragai, Ho, G., Takamatsu, Y., Wada, R., Sugama, S., Takenouchi, T., Masliah, E., and Hashimoto, M., “Adiponectin Paradox as a Therapeutic Target in Alzheimer's Disease.”, J Alzheimers Dis, vol. 76, no. 4, pp. 1249-1253, 2020.
K. M. Hawkins and Sergio, L. E., “Adults at Increased Alzheimer's Disease Risk Display Cognitive-Motor Integration Impairment Associated with Changes in Resting-State Functional Connectivity: A Preliminary Study.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1161-72, 2016.
B. Dubois, Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. Luis, Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., Cappa, S., Crutch, S., Engelborghs, S., Frisoni, G. B., Fox, N. C., Galasko, D., Habert, M. - O., Jicha, G. A., Nordberg, A., Pasquier, F., Rabinovici, G., Robert, P., Rowe, C., Salloway, S., Sarazin, M., Epelbaum, S., de Souza, L. C., Vellas, B., Visser, P. J., Schneider, L., Stern, Y., Scheltens, P., and Cummings, J. L., “Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.”, Lancet Neurol, vol. 13, no. 6, pp. 614-29, 2014.

Pages